ESC 2011: HighlightsDr. Edgar F. Hernández Paz, M.A.G.C, F.A.C.C.

ARISTOTLEApixaban vs. Warfarin in Patients with Atrial Fibrillation

ASCOT-11The Anglo-Scandinavian Cardiac Outcomes Trial Lipid Lowering Arm (ASCOT-LLA) 11 Year Mortality Follow-Up in the UK

dal-VESSELVascular Effects and Safety of Dalcetrapib in Patients with or at Risk of Coronary Heart Disease

*FMD: Flow Mediated Vasodilation

PUREThe Prospective Urban Rural Epidemiologic Study

EMPHASIS-HFThe Effect of Eplerenone vs. Placebo on Cardiovascular Mortality or Heart Failure Hospitalization in Subjects with NYHA Class II Chronic Systolic Heart Failure: An Analysis of the “High Risk Groups”

N=1364

N=1373

SHIFTEffect of Heart Rate Reduction with Ivabradine on Left Ventricular Volume and Function: Results of the SHIFT Echocardiographic Substudy

CORPColchicine for Recurrent Pericarditis

PRODIGYProlonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study

EXAMINATIONA Clinical Evaluation of Xience-V Stent in Acute Myocardial Infarction

The Italian Elderly-ACS Randomised TrialEarly Aggressive vs. Initially Conservative Strategy in Elderly Patients witn non-ST elevation Acute Coronary Syndrome

¡Gracias!